These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9334419

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide Y.
    Hall AC, Earle-Cruikshanks G, Harrington ME.
    Eur J Neurosci; 1999 Oct; 11(10):3424-32. PubMed ID: 10564350
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro.
    Biello SM, Golombek DA, Harrington ME.
    Neuroscience; 1997 Apr; 77(4):1049-57. PubMed ID: 9130786
    [Abstract] [Full Text] [Related]

  • 5. Neuropeptide Y, GABA and circadian phase shifts to photic stimuli.
    Lall GS, Biello SM.
    Neuroscience; 2003 Apr; 120(4):915-21. PubMed ID: 12927198
    [Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.
    Obrietan K, van den Pol AN.
    J Neurosci; 1996 May 15; 16(10):3521-33. PubMed ID: 8627385
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuropeptide Y blocks GABAB-induced phase-shifts of the suprachiasmatic circadian clock in vitro.
    Biggs KR, Prosser RA.
    Brain Res; 1999 Mar 13; 821(2):461-6. PubMed ID: 10064833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y applied in vitro can block the phase shifts induced by light in vivo.
    Yannielli PC, Harrington ME.
    Neuroreport; 2000 May 15; 11(7):1587-91. PubMed ID: 10841381
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glutamate blocks serotonergic phase advances of the mammalian circadian pacemaker through AMPA and NMDA receptors.
    Prosser RA.
    J Neurosci; 2001 Oct 01; 21(19):7815-22. PubMed ID: 11567072
    [Abstract] [Full Text] [Related]

  • 14. Tetrodotoxin blocks NPY-induced but not muscimol-induced phase advances of wheel-running activity in Syrian hamsters.
    Huhman KL, Marvel CL, Gillespie CF, Mintz EM, Albers HE.
    Brain Res; 1997 Oct 24; 772(1-2):176-80. PubMed ID: 9406970
    [Abstract] [Full Text] [Related]

  • 15. NPY opposes PACAP phase shifts via receptors different from those involved in NPY phase shifts.
    Harrington ME, Hoque S.
    Neuroreport; 1997 Aug 18; 8(12):2677-80. PubMed ID: 9295099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
    Huhman KL, Albers HE.
    Peptides; 1994 Aug 18; 15(8):1475-8. PubMed ID: 7700850
    [Abstract] [Full Text] [Related]

  • 18. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn.
    McArthur AJ, Hunt AE, Gillette MU.
    Endocrinology; 1997 Feb 18; 138(2):627-34. PubMed ID: 9002996
    [Abstract] [Full Text] [Related]

  • 19. Circadian rhythms in the suprachiasmatic nucleus are temperature-compensated and phase-shifted by heat pulses in vitro.
    Ruby NF, Burns DE, Heller HC.
    J Neurosci; 1999 Oct 01; 19(19):8630-6. PubMed ID: 10493763
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.